Vivo Bio Tech

40.10
-0.81
(-1.98%)
Market Cap
66.00 Cr
EPS
1.70
PE Ratio
9.49
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
56.90
52 Week low
31.20
PB Ratio
1.08
Debt to Equity
1.27
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
289.80 3,313.90 23.15 660.50 16.68 137 -8.47 28.05
40.10 66.00 9.49 45.50 -13.00 3 -38.46 45.03
1.01 41.50 20.80 21.30 -66.19 1 700.00 49.51
60.97 18.30 47.44 0.20 -92.86 0 0.20 58.58
Growth Rate
Revenue Growth
-13.00 %
Net Income Growth
-3.85 %
Cash Flow Change
4.65 %
ROE
-9.20 %
ROCE
-4.64 %
EBITDA Margin (Avg.)
12.72 %

Quarterly Financial Results

Quarterly Financials
Mar 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
12
14
14
14
13
14
14
14
9
15
12
16
13
10
13
15
11
13
14
15
12
9
13
12
10
17
12
Expenses
10
10
11
15
10
10
10
13
6
9
7
12
7
6
7
14
7
8
9
8
7
4
7
6
6
6
7
EBITDA
3
4
3
-1
4
4
4
1
3
6
5
4
6
4
6
2
5
5
5
7
5
5
6
5
4
10
6
Operating Profit %
22 %
28 %
22 %
-9 %
28 %
27 %
27 %
9 %
31 %
41 %
40 %
25 %
44 %
38 %
45 %
11 %
42 %
37 %
36 %
48 %
39 %
52 %
50 %
46 %
43 %
47 %
45 %
Depreciation
1
1
1
1
1
1
2
1
1
1
1
2
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
Interest
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
2
Profit Before Tax
1
2
1
-3
2
2
2
-1
1
4
3
1
2
1
3
-2
1
1
1
3
0
1
2
1
0
6
2
Tax
0
-1
0
-0
0
-1
0
-0
-0
2
1
1
1
1
2
-1
0
0
0
1
0
0
1
1
0
1
1
Net Profit
1
3
1
-3
1
2
1
-0
1
2
2
0
1
0
1
-1
0
0
0
2
0
0
1
1
0
5
1
EPS in ₹
0.82
2.48
1.27
-2.41
0.94
1.83
1.02
-0.31
0.76
1.63
1.73
0.22
0.87
0.20
0.97
-0.49
0.22
0.08
0.10
1.38
0.10
0.22
0.89
0.50
0.11
3.51
0.55

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
41
46
51
60
55
64
80
123
123
137
Fixed Assets
20
24
29
28
30
35
52
95
89
80
Current Assets
22
22
20
28
25
27
27
26
32
47
Capital Work in Progress
0
0
3
4
0
0
0
1
2
9
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
22
22
20
28
25
29
27
26
32
48
Total Liabilities
41
46
51
60
55
64
80
123
123
137
Current Liabilities
28
20
17
25
19
21
22
23
25
38
Non Current Liabilities
4
15
22
15
9
10
15
52
46
45
Total Equity
9
10
13
19
27
33
43
47
52
54
Reserve & Surplus
-0
1
3
7
15
20
28
32
37
40
Share Capital
9
9
9
10
12
13
13
14
15
15

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-1
1
-11
3
-4
1
0
1
-0
0
Investing Activities
-2
-7
-12
-5
-4
-10
-23
-51
-4
-8
Operating Activities
2
9
-6
11
-1
9
14
17
15
16
Financing Activities
-1
-0
7
-3
1
2
9
35
-11
-8

Share Holding

% Holding
Mar 2021
Apr 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
May 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
37.29 %
39.30 %
39.84 %
39.84 %
39.84 %
39.67 %
42.16 %
42.16 %
42.16 %
42.16 %
42.08 %
42.08 %
42.08 %
42.08 %
42.08 %
42.08 %
42.08 %
38.88 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
11.99 %
10.78 %
12.12 %
12.85 %
14.96 %
20.66 %
20.63 %
20.78 %
21.46 %
22.99 %
23.72 %
23.86 %
23.43 %
23.52 %
25.35 %
26.11 %
26.51 %
35.03 %
Others
50.72 %
49.92 %
48.05 %
47.32 %
45.20 %
39.67 %
37.21 %
37.07 %
36.39 %
34.85 %
34.20 %
34.06 %
34.49 %
34.40 %
32.57 %
31.81 %
31.41 %
26.08 %
No of Share Holders
8,029
8,043
8,098
10,263
11,364
12,455
12,582
12,632
13,036
13,048
13,062
12,989
13,006
15,615
18,971
18,852
19,545
21,167

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Allotment
4 hours ago
Announcement under Regulation 30 (LODR)-Allotment
1 day ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
1 day ago
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Feb 07, 2025, 18:51
Proceedings Of EGM
Feb 07, 2025, 18:49
Shareholder Meeting / Postal Ballot-Outcome of EGM
Feb 07, 2025, 18:44
Integrated Filing (Financial)
Feb 05, 2025, 17:09
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jan 17, 2025, 12:03
Corrigendum To EGM Notice
Jan 16, 2025, 18:00
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 13, 2025, 15:28
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jan 13, 2025, 13:31
Launch Of Large Animal Facility
Jan 13, 2025, 10:11
Notice Convening Extra-Ordinary General Meeting (EGM No. 01/2024-2025) Of The Members Of Vivo Bio Tech Limited Scheduled To Be Held On Friday February 07 2025 At 12:30 P.M. (Noon) Through Video Confer
Jan 11, 2025, 16:04
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jan 11, 2025, 10:43
Announcement under Regulation 30 (LODR)-Issue of Securities
Jan 09, 2025, 19:27
Board Meeting Outcome for Outcome Of The Board Meeting
Jan 09, 2025, 18:35
Third Quarter And Nine Months Ended December 31 2024.
Jan 09, 2025, 18:33
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Jan 06, 2025, 15:39
Board Meeting Intimation for Convening Meeting Of The Board Of Directors On Thursday January 09 2024
Jan 02, 2025, 15:17
Closure of Trading Window
Dec 30, 2024, 14:48
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Dec 23, 2024, 15:58

Technical Indicators

RSI(14)
Neutral
47.05
ATR(14)
Less Volatile
3.63
STOCH(9,6)
Neutral
47.36
STOCH RSI(14)
Neutral
75.05
MACD(12,26)
Bearish
-0.28
ADX(14)
Strong Trend
28.29
UO(9)
Bearish
54.40
ROC(12)
Downtrend And Accelerating
-6.68
WillR(14)
Neutral
-31.73